Below you will find a collection of articles from Hematology, the ASH Education Program, written by experts in the field about current treatments for chronic leukemia. To learn more about leukemia, please see our general information page about the disease. A number of links to organizations that inform and support patients with leukemia and their families are also available.

Chronic Lymphocytic Leukemia (CLL)

• Alemtuzumab Use In Relapsed and Refractory Chronic Lymphocytic Leukemia (2011) 
• Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia (2011) 
• Using the Biology of Chronic Lymphocytic Leukemia to Choose Treatment (2011) 
• The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia (2011) 
• Understanding and Managing Ultra High-Risk Chronic Lymphocytic Leukemia (2010) 
• Novel Insights into the Biology of CLL (2010) 
• Prognostic Markers and Stratification of Chronic Lymphocytic Leukemia (2010) 
• Treatment of Younger Patients with Chronic Lymphocytic Leukemia (2010) 
• Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion (2010) 
• Allotransplantation for Chronic Lymphocytic Leukemia (2009) 
• Predicting Clinical Outcome in CLL: How and Why (2009) 
• Monoclonal B-Cell Lymphocytosis (2009) 
• State-of-the-Art Treatment of Chronic Lymphocytic Leukemia (2009) 
• Chronic Lymphocytic Leukemia: An Historical Perspective (2008) 
• Molecular Profiling in CLL (2008) 
• Disease-Specific Complications of Chronic Lymphocytic Leukemia (2008) 
• Familial CLL: Genes and Environment (2007) 

Chronic Myeloid (Granulocytic) Leukemia (CML)

• Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease (2011) 
• Minimal Residual Disease and Discontinuation of Therapy in Chronic Myeloid Leukemia: Can We Aim at a Cure? (2011) 
• Tyrosine Kinase Inhibitor Therapy for Chronic Myeloid Leukemia: Approach to Patients with Treatment-Naive or Refractory Chronic-Phase Disease (2011) 
• Chronic Myeloid Leukemia 2010: Where Are We Now and Where Can We Go? (2010) 
• Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia and Recent Therapeutic Strategies to Overcome Resistance (2009) 
• Monitoring Disease Response to Tyrosine Kinase Inhibitor Therapy in CML (2009) 
• Chronic Myeloid Leukemia: An Historical Perspective (2008) 

back to top